Literature DB >> 23685662

Cardiac resynchronization therapy in becker muscular dystrophy.

George Andrikopoulos1, Spiros Kourouklis, Chrysanthi Trika, Stylianos Tzeis, Ioannis Rassias, Christos Papademetriou, Apostolos Katsivas, George Theodorakis.   

Abstract

A 44-year-old male patient with known Becker muscular dystrophy and concomitant non-ischemic dilated cardiomyopathy presented to our department because of worsening heart failure and presyncope. Upon admission, the patient was in New York Heart Association functional class III despite optimal pharmacological treatment; his ECG showed sinus rhythm with left bundle branch block and a wide QRS complex. Non-sustained ventricular tachycardia was recorded during 24-hour Holter monitoring. A complete three-dimensional echocardiographic study was performed and documented the dilatation and concomitant hypertrabeculation of the left ventricle (LV), with severely depressed systolic LV performance (ejection fraction 20%), as well as mechanical dyssynchrony--mainly in terms of intraventricular delay. A biventricular cardioverter-defibrillator (CRT-D) was implanted in this patient, with the LV lead in a lateral vein and the right ventricular defibrillating lead in the apical part of the interventricular septum. Echocardiography-guided device programming was performed in order to achieve the optimal atrio-, inter-, and intraventricular resynchronization. The patient's clinical condition was substantially improved within one month after the implantation.

Entities:  

Mesh:

Year:  2013        PMID: 23685662

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  5 in total

Review 1.  Treatment of dystrophin cardiomyopathies.

Authors:  Josef Finsterer; Linda Cripe
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

Review 2.  Becker muscular dystrophy: case report, review of the literature, and analysis of differentially expressed hub genes.

Authors:  Min Li; Yongli Han; Shuying Wang; Yajie Yu; Mengling Liu; Yingfeng Xia; Ze'an Weng; Ling Zhou; Xiaoyan He; Jun Wang; Zhi He; Liang Yu; Yunhong Zha
Journal:  Neurol Sci       Date:  2021-11-03       Impact factor: 3.307

3.  Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.

Authors:  John P Bourke; Teofila Bueser; Rosaline Quinlivan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-16

Review 4.  Heart Disease in Disorders of Muscle, Neuromuscular Transmission, and the Nerves.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

Review 5.  Are there real benefits to implanting cardiac devices in patients with end-stage dilated dystrophinopathic cardiomyopathy? Review of literature and personal results.

Authors:  Alberto Palladino; Andrea A Papa; Salvatore Morra; Vincenzo Russo; Manuela Ergoli; Anna Rago; Chiara Orsini; Gerardo Nigro; Luisa Politano
Journal:  Acta Myol       Date:  2019-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.